TP53 and acute myeloid leukemia: TP53-mutated AML displays marked baseline T cell dysfunction and senescence, and recent single-cell analyses have shown that ASXL1- and RUNX1-mutated AML share this phenotype, characterized by a predominance of senescent-like CD8+ T cells [8,9,10,11,12,13].